financetom
Business
financetom
/
Business
/
Royal Bank of Canada Beats Q2 Estimates, Raises Quarterly Dividend by 3%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Royal Bank of Canada Beats Q2 Estimates, Raises Quarterly Dividend by 3%
May 30, 2024 4:13 AM

06:53 AM EDT, 05/30/2024 (MT Newswires) -- Royal Bank of Canada ( RY ) on Thursday beat estimates for second quarter results amid "record" earnings in capital markets as well as improved results in personal & commercial banking, wealth management and insurance.

The bank reported fiscal second-quarter adjusted net income of $4.20 billion, or $2.92 per diluted share, up 11% from $3.79 billion, or $2.68 per diluted share, a year earlier. Analysts surveyed by Capital IQ expected $2.74.

On a reported basis, net income for the quarter was $3.95 billion, or $2.74 per diluted share, up from $3.68 billion, or $2.60 per diluted share, a year earlier. Three analysts polled by Capital IQ expected $2.47.

Revenue for the quarter ended April 30 was $14.15 billion, up from $12.45 billion a year earlier. Analysts polled by Capital IQ expected $13.60 billion.

The company reported an adjusted return on equity of 15.5% in the quarter versus 15.3% a year earlier. Provision for credit losses for fiscal Q2 was $920 million, up 53% from $600 million a year earlier.

The bank on March 28 closed the purchase of HSBC Bank Canada. The inclusion of HSBC Canada results decreased net income by $51 million, reflecting $200 million of initial PCL on purchased performing financial assets.

Additionally, the bank noted that transaction and integration costs had an unfavorable impact while management of closing capital volatility benefitted the results.

Royal Bank of Canada's ( RY ) board raised its quarterly common share dividend by 3% to $1.42 per share. The dividend will be paid by Aug. 23 to shareholders of record at the close of business on July 25.

The bank's shares fell 1.6% in Canada yesterday and jumped 6% in premarket U.S. trading on Thursday.

The year-ago amounts have been restated from those previously presented following the adoption of IFRS 17, effective Nov. 1, 2023.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lufthansa slashes 2024 outlook, citing strikes and capacity snags
Lufthansa slashes 2024 outlook, citing strikes and capacity snags
Apr 15, 2024
BERLIN (Reuters) -Lufthansa slashed its 2024 earnings outlook on Monday, blaming a series of strikes and a slower than planned ramp-up of capacity, in a profit warning that sent its share price sliding by more than 4% to a five-month low. The German flag carrier now expects adjusted earnings before interest and taxes (EBIT) of 2.2 billion euros ($2.3 billion)...
Tapestry merger with Versace owner Capri gets EU, Japan approval
Tapestry merger with Versace owner Capri gets EU, Japan approval
Apr 15, 2024
(Reuters) - Coach parent Tapestry's $8.5 billion deal to buy Michael Kors owner Capri Holdings ( CPRI ) has received regulatory clearance from the European Union and Japan, the companies said on Monday. The merger, which would bring top luxury labels such as Tapestry's Kate Spade, Stuart Weitzman and Capri's Jimmy Choo and Versace under one roof, still awaits approval...
Air Products receives funding to build hydrogen refueling stations in Germany
Air Products receives funding to build hydrogen refueling stations in Germany
Apr 15, 2024
April 15 (Reuters) - Industrial gas manufacturer Air Products and Chemicals ( APD ) said on Monday it has received funding to build two hydrogen refueling stations in Germany, which are capable of fueling a range of vehicles including trucks. The Pennsylvania-based company said it will build, own and operate the two high-capacity stations. The state of North Rhine-Westphalia, the...
Soligenix Shares Rise After Active Ingredient in MarVax Gets US FDA's Orphan Drug Designation
Soligenix Shares Rise After Active Ingredient in MarVax Gets US FDA's Orphan Drug Designation
Apr 15, 2024
11:19 AM EDT, 04/15/2024 (MT Newswires) -- Soligenix ( SNGX ) shares rose 58% recent Monday trading after the company said the active ingredient in MarVax received an orphan drug designation from the US Food and Drug Administration. The active ingredient in MarVax, the subunit protein vaccine of recombinantly termed Marburg marburgvirus glycoprotein, received the designation for the prevention and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved